Related Experiment Video
Updated: Jun 3, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
p53: The Multifaceted Roles of Covalent Modifications in Cancer
Tatiana A Grigoreva1, Angelina A Romanova1, Vyacheslav G Tribulovich1
1St. Petersburg State Institute of Technology, St-Petersburg 190013, Russia.
Abstract:
The p53 protein has attracted huge research interest over several decades due to its role as one of the most important tumor suppressors in mammals, which orchestrates a synchronous response from normal cells in the body to various forms of stress. The diverse cellular activities of the p53 protein are regulated mainly via its post-translational modifications (PTMs). PTMs affect p53 on several levels: at the level of the assembly of tetrameric complexes on DNA to transactivate its target genes, at the level of the assembly of tetrameric complexes on DNA to transactivate its target genes; at the level of proteolysis in the absence of stress; and on the contrary, at the level of augmented protein stability in response to stress signals. Disruptions in these regulatory mechanisms can lead to deviations from normal cellular function, boosting tumor initiation and progression. Conversely, targeted interventions in these pathways could prove beneficial for the development of antitumor therapies. Advancing our understanding of p53 modifiers and the proteins involved in its regulation equips researchers with an expanded toolkit for studying cellular processes and for developing biologically active molecules that influence p53-mediated responses.
Insights
The p53 protein, a key tumor suppressor, is regulated by post-translational modifications (PTMs). Understanding these PTMs is crucial for developing new cancer therapies by targeting p53 pathways.
Area of Science:
- Molecular Biology
- Biochemistry
- Oncology
Background:
- The p53 protein is a critical tumor suppressor in mammals.
- Its cellular functions are primarily regulated by post-translational modifications (PTMs).
- Dysregulation of p53 pathways contributes to cancer initiation and progression.
Purpose of the Study:
- To review the regulatory mechanisms of p53, focusing on PTMs.
- To highlight the importance of understanding p53 regulation for cancer therapy development.
- To emphasize the potential of targeting p53 modifiers for therapeutic interventions.
Main Methods:
- Literature review of p53 regulation and PTMs.
- Analysis of the impact of PTMs on p53 activity and stability.
- Exploration of therapeutic strategies targeting p53 pathways.
Main Results:
- PTMs critically influence p53's ability to bind DNA, form tetramers, and regulate target gene expression.
- PTMs control p53 protein stability, promoting degradation in unstressed cells and stabilization under stress.
- Understanding these modifications provides insights into cancer development.
Conclusions:
- Targeted modulation of p53 PTMs offers a promising avenue for novel antitumor therapies.
- Further research into p53 modifiers can expand the toolkit for cancer research and drug development.
- A deeper comprehension of p53 regulation is essential for advancing cancer treatment strategies.
Related Concept Videos
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage can Stall the Cell Cycle
Negative Regulator Molecules
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

